Ximelagatran simplifies stroke prevention for patients with AF

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1419, 2004-01, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Warfarin superior for stroke prevention in patients with AF

Inpharma, Vol. 1, Iss. 1601, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Ximelagatran Cost Effectiveness for Stroke Prevention in Atrial Fibrillation

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 35, Iss. 4, 2005-12 ,pp. : 279-283

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ximelagatran Compared with Warfarin for the Prevention of Systemic Embolism and Stroke. An Imputed Placebo Analysis

By Berry Colin Norrie John McMurray John

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 2, 2005-03 ,pp. : 149-151

Springer Publishing Company

Access to resources Recommend Favorite

Dabigatran etexilate: a dab hand for stroke prevention in AF

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 642, 2011-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Idraparinux risky for embolism prevention in AF patients

Inpharma, Vol. 1, Iss. 1597, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite